Pain Management News

Despite a lack of “gold standard” evidence surrounding cannabis use for musculoskeletal pain, rheumatologists must not turn a blind eye to how such products are used by their patients in the real world, according to researchers.

A single saline injection, openly prescribed as a placebo, yielded approximately 1 month of chronic back pain improvement, along with longer-term benefits in depression and sleep, according to data published in JAMA Network Open.

Knee osteoarthritis pain responds best to exercise combined with a non-exercise intervention, such as diet, while hip osteoarthritis moderately benefits from non-exercise interventions vs. resistance exercise, according to data.

SAN DIEGO — Improving depressive symptoms can reduce patients’ chronic pain, according to a presenter at the 2024 Congress of Clinical Rheumatology West.

In the third episode of the NSAIDs saga, we focus on COX-2 inhibition! Did the hopes and dreams of selective COX-2 inhibition pan out? What can the rise and fall of VIOXX teach us about physiology?

Opioid use in patients with autoimmune rheumatic disease has decreased 15% annually since 2014, while use of non-opioid options for pain management has either increased or stabilized, according to data published in The Lancet Rheumatology.

An eight-item questionnaire, called Central Aspects of Pain, reliably measures nociplastic pain across a variety of chronically painful musculoskeletal conditions, according to data published in Rheumatology.

Nearly one-quarter of outpatient visits by patients with systemic autoimmune rheumatic diseases in the United States between 2006 and 2019 resulted in an opioid prescription, according to data published in Arthritis Care & Research.

In this episode, we dive into the story of aspirin and the development of ibuprofen, ending with the experiments that showed the mechanism of how aspirin actually works.